Professor
Chief, Division of Cardiothoracic Surgery
Division of Cardiothoracic Surgery
Minimally Invasive Thoracic and Cardiac Surgery
Medical School
Chicago Medical School, Chicago, IL
Internship
General Surgery, University of Tennessee Medical Center
Residency
General Surgery, University of Tennessee Medical Center
Fellowship
Cardiothoracic Surgery, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL
American Board of Thoracic Surgery
American College of Surgeons
International College of Surgeons
Society of Thoracic Surgeons
Fogelson B, Black W, Goodwin RP, Dieter R 3rd, Baljepally R.
Asymptomatic aorto-atrial fistula secondary to surgical repair of ascending aortic dissection: When to do nothing. JACC Case Rep. 2022 Jul 20;4(14):868-870. doi: 10.1016/j.jaccas.2022.04.013. eCollection 2022 Jul 20.
Fogelson B, Black W, Goodwin RP, Dieter R 3rd, Baljepally R.
Asymptomatic aorto-atrial fistula secondary to surgical repair of ascending aortic dissection: When to do nothing. JACC Case Rep. 2022 Jul 20;4(14):868-870. doi: 10.1016/j.jaccas.2022.04.013. eCollection 2022 Jul 20.
Baljepally R, Tahir H, Goodwin RP, Livesay J, Fogelson B, Patel C, Coombes T, Wadi G, Dieter R.
Comparison of transcatheter aortic valve implantation outcomes between normal-flow, low-gradient severe aortic stenosis and normal-flow, high-gradient severe aortic stenosis. Cardiovasc Revasc Med. 2022 Jun;39:12-17. doi: 10.1016/j.carrev.2021.10.020. Epub 2021 Nov 2.
Baljepally R, Tahir H, Goodwin RP, Livesay J, Fogelson B, Patel C, Coombes T, Wadi G, Dieter R.
Comparison of transcatheter aortic valve implantation outcomes between normal-flow, low-gradient severe aortic stenosis and normal-flow, high-gradient severe aortic stenosis. Cardiovasc Revasc Med. 2022 Jun;39:12-17. doi: 10.1016/j.carrev.2021.10.020. Epub 2021 Nov 2.
Grimsley LB, West PC, McAdams CD, Bush CA, Kirkpatrick SS, Arnold JD, Buckley MR, Dieter RA, Freeman MB, McNally MM, Stevens SL, Grandas OH, Mountain DJH.
Liposomal nanocarriers designed for sub-endothelial matrix targeting under vascular flow conditions. Pharmaceutics. 2021 Oct 31;13(11):1816. Available in PubMed: Nov 2021.
Grimsley LB, West PC, McAdams CD, Bush CA, Kirkpatrick SS, Arnold JD, Buckley MR, Dieter RA, Freeman MB, McNally MM, Stevens SL, Grandas OH, Mountain DJH.
Liposomal nanocarriers designed for sub-endothelial matrix targeting under vascular flow conditions. Pharmaceutics. 2021 Oct 31;13(11):1816. Available in PubMed: Nov 2021.
Grimsley LB, West PC, McAdams CD, Bush CA, Kirkpatrick SS, Arnold JD, Buckley MR, Dieter RA, Freeman MB, McNally MM, Stevens SL, Grandas OH, Mountain DJH.
Liposomal nanocarriers designed for sub-endothelial matrix targeting under vascular flow conditions. Pharmaceutics. 2021 Oct 31;13(11):1816. Available in PubMed: Nov 2021.
Baljepally R, Tahir H, Goodwin RP, Livesay J, Fogelson B, Patel C, Coombes T, Wadi G, Dieter R 3rd.
Comparison of transcatheter aortic valve implantation outcomes between normal flow low gradient severe aortic stenosis and normal flow high gradient severe aortic stenosis. Cardiovascular Revascularization Medicine. 2021 Nov 2:S1553-8389(21)00725-9.
Baljepally R, Tahir H, Goodwin RP, Livesay J, Fogelson B, Patel C, Coombes T, Wadi G, Dieter R 3rd.
Comparison of transcatheter aortic valve implantation outcomes between normal flow low gradient severe aortic stenosis and normal flow high gradient severe aortic stenosis. Cardiovascular Revascularization Medicine. 2021 Nov 2:S1553-8389(21)00725-9.
Baljepally R, Tahir H, Goodwin RP, Livesay J, Fogelson B, Patel C, Coombes T, Wadi G, Dieter R 3rd.
Comparison of transcatheter aortic valve implantation outcomes between normal flow low gradient severe aortic stenosis and normal flow high gradient severe aortic stenosis. Cardiovascular Revascularization Medicine. 2021 Nov 2:S1553-8389(21)00725-9.
Fisher RK III, West PC, Mattern-Schain SI, Best MD, Kirkpatrick SS, Dieter RA III, Arnold JD, Buckley MR, McNally MM, Freeman MB, Grandas OH, Mountain DJH.
Advances in the formulation and assembly of non-cationic lipid nanoparticles for the medical application of gene therapeutics. Nanomaterials (Basel). 2021 Mar;11(3)825.
Livesay J, Fogelson B, Stephens S, Patel C, Dieter W, Tahir H, Wiseman B, Baljepally R. The Use Of Cha2ds2-vasc Score To Predict Functional Outcomes Of Mechanical Thrombectomy. Presented at American Heart Association’s annual Scientific Sessions 2022; 2022 November-5; Virtual.
McAdams CD, Grimsley LB, West PC, Arnold JD, Buckley RM, Dieter RA, Freeman MB, Grandas OH, McNally MM, Stevens SL. Lipid Nanoparticles Functionalized for Sub-Endothelial Matrix Targeting in Lower Extremity Vessels. Presented at Academic Surgical Congress 2022; 2022 February-1; Orlando, Florida.
Grimsely L, West P, Arnold J, Buckley R, Dieter R, Freeman M, Grandas O, McNally M, Stevens S, Mountain D. Lipid Nanoparticles Functionlized for Sub-Endothelial Matrix Targeting in Lower Extremity Vessels. Presented at Academic Surgical Congress ; 2022 February-1; Orlando, Florida.
McAdams C, Grimsley L, West P, Arnold J, Buckley R, Dieter R, Freeman M, Grandas O, McNally M, Stevens S, Mountain D. Liposomal nanoparticles functionalized for sub-endothelial matrix targeting in human lower extremity vessels. Presented at Tennessee Chapter of the American College of Surgeons; 2021 Aug 6-8; Memphis, TN.
Grimsley L, Fisher R, Dieter R, Arnold J, Buckley R, McNally M, Freeman M, Mountain D, Grandas O. Liposomal nanocarriers designed for sub-endothelial matrix targeting under vascular sheer stress. Presented at Tennessee American College of Surgeons Annual Meeting; 2019 Aug 8-11; Chattanooga, TN.
Grimsley LB, Dieter RA, Arnold JD, Buckley MR, McNally MM, Freeman MB, Grandas OH, Mountain DJH. Dual-ligand modified liposomal nanoparticles multifunctionalized for spatially controlled delivery of gene therapeutics. Presented at Society of Vascular Surgery Vascular Research Initiatives Conference; 2019 May 13; Boston, MA.
TopThe University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2023